COVID-19 Impact on Antifungal Treatment Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Antifungal Treatment Industry
1.7 COVID-19 Impact: Antifungal Treatment Market Trends
2 Global Antifungal Treatment Quarterly Market Size Analysis
2.1 Antifungal Treatment Business Impact Assessment - COVID-19
2.1.1 Global Antifungal Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Antifungal Treatment Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Antifungal Treatment Quarterly Market Size, 2019 VS 2020
3.2 By Players, Antifungal Treatment Headquarters and Area Served
3.3 Date of Key Players Enter into Antifungal Treatment Market
3.4 Key Players Antifungal Treatment Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Antifungal Treatment Segments, By Type
4.1 Introduction
1.4.1 Azoles
1.4.2 Echinocandins
1.4.3 Polyenes
1.4.4 Allyamines
1.4.5 Other
4.2 By Type, Global Antifungal Treatment Market Size, 2019-2021
5 Impact of Covid-19 on Antifungal Treatment Segments, By Application
5.1 Overview
5.5.1 Dermatophytosis
5.5.2 Aspergillosis
5.5.3 Candidiasis
5.5.4 Other
5.2 By Application, Global Antifungal Treatment Market Size, 2019-2021
5.2.1 By Application, Global Antifungal Treatment Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Business Overview
7.1.2 Novartis Antifungal Treatment Quarterly Revenue, 2020
7.1.3 Novartis Antifungal Treatment Product Introduction
7.1.4 Novartis Response to COVID-19 and Related Developments
7.2 Pfizer
7.2.1 Pfizer Business Overview
7.2.2 Pfizer Antifungal Treatment Quarterly Revenue, 2020
7.2.3 Pfizer Antifungal Treatment Product Introduction
7.2.4 Pfizer Response to COVID-19 and Related Developments
7.3 Sanofi-Aventis
7.3.1 Sanofi-Aventis Business Overview
7.3.2 Sanofi-Aventis Antifungal Treatment Quarterly Revenue, 2020
7.3.3 Sanofi-Aventis Antifungal Treatment Product Introduction
7.3.4 Sanofi-Aventis Response to COVID-19 and Related Developments
7.4 Merck&Co
7.4.1 Merck&Co Business Overview
7.4.2 Merck&Co Antifungal Treatment Quarterly Revenue, 2020
7.4.3 Merck&Co Antifungal Treatment Product Introduction
7.4.4 Merck&Co Response to COVID-19 and Related Developments
7.5 Enzon Pharmaceuticals
7.5.1 Enzon Pharmaceuticals Business Overview
7.5.2 Enzon Pharmaceuticals Antifungal Treatment Quarterly Revenue, 2020
7.5.3 Enzon Pharmaceuticals Antifungal Treatment Product Introduction
7.5.4 Enzon Pharmaceuticals Response to COVID-19 and Related Developments
7.6 Bayer AG
7.6.1 Bayer AG Business Overview
7.6.2 Bayer AG Antifungal Treatment Quarterly Revenue, 2020
7.6.3 Bayer AG Antifungal Treatment Product Introduction
7.6.4 Bayer AG Response to COVID-19 and Related Developments
7.7 Astellas Pharma
7.7.1 Astellas Pharma Business Overview
7.7.2 Astellas Pharma Antifungal Treatment Quarterly Revenue, 2020
7.7.3 Astellas Pharma Antifungal Treatment Product Introduction
7.7.4 Astellas Pharma Response to COVID-19 and Related Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Business Overview
7.8.2 GlaxoSmithKline Antifungal Treatment Quarterly Revenue, 2020
7.8.3 GlaxoSmithKline Antifungal Treatment Product Introduction
7.8.4 GlaxoSmithKline Response to COVID-19 and Related Developments
7.9 Abbott
7.9.1 Abbott Business Overview
7.9.2 Abbott Antifungal Treatment Quarterly Revenue, 2020
7.9.3 Abbott Antifungal Treatment Product Introduction
7.9.4 Abbott Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Antifungal Treatment Assessment
Table 9. COVID-19 Impact: Antifungal Treatment Market Trends
Table 10. COVID-19 Impact Global Antifungal Treatment Market Size
Table 11. Global Antifungal Treatment Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Antifungal Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Antifungal Treatment Market Growth Drivers
Table 14. Global Antifungal Treatment Market Restraints
Table 15. Global Antifungal Treatment Market Opportunities
Table 16. Global Antifungal Treatment Market Challenges
Table 17. By Players, Antifungal Treatment Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Antifungal Treatment Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Antifungal Treatment Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Antifungal Treatment Market
Table 21. Key Players Antifungal Treatment Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Antifungal Treatment Market Size 2019-2021, (US$ Million)
Table 24. Global Antifungal Treatment Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Antifungal Treatment Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Antifungal Treatment Market Size, 2019-2021 (US$ Million)
Table 57. Novartis Business Overview
Table 58. Novartis Antifungal Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Novartis Antifungal Treatment Product
Table 60. Novartis Response to COVID-19 and Related Developments
Table 61. Pfizer Business Overview
Table 62. Pfizer Antifungal Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Pfizer Antifungal Treatment Product
Table 64. Pfizer Response to COVID-19 and Related Developments
Table 65. Sanofi-Aventis Business Overview
Table 66. Sanofi-Aventis Antifungal Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Sanofi-Aventis Antifungal Treatment Product
Table 68. Sanofi-Aventis Response to COVID-19 and Related Developments
Table 69. Merck&Co Business Overview
Table 70. Merck&Co Antifungal Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Merck&Co Antifungal Treatment Product
Table 72. Merck&Co Response to COVID-19 and Related Developments
Table 73. Enzon Pharmaceuticals Business Overview
Table 74. Enzon Pharmaceuticals Antifungal Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Enzon Pharmaceuticals Antifungal Treatment Product
Table 76. Enzon Pharmaceuticals Response to COVID-19 and Related Developments
Table 77. Bayer AG Business Overview
Table 78. Bayer AG Antifungal Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Bayer AG Antifungal Treatment Product
Table 80. Bayer AG Response to COVID-19 and Related Developments
Table 81. Astellas Pharma Business Overview
Table 82. Astellas Pharma Antifungal Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Astellas Pharma Antifungal Treatment Product
Table 84. Astellas Pharma Response to COVID-19 and Related Developments
Table 85. GlaxoSmithKline Business Overview
Table 86. GlaxoSmithKline Antifungal Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. GlaxoSmithKline Antifungal Treatment Product
Table 88. GlaxoSmithKline Response to COVID-19 and Related Developments
Table 89. Abbott Business Overview
Table 90. Abbott Antifungal Treatment Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Abbott Antifungal Treatment Product
Table 92. Abbott Response to COVID-19 and Related Developments
List of FiguresFigure 1. Antifungal Treatment Product Picture
Figure 2. Antifungal Treatment Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Antifungal Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Antifungal Treatment Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Antifungal Treatment Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Antifungal Treatment Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Antifungal Treatment Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Antifungal Treatment Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Antifungal Treatment Market Size Market Share, 2019-2021